Use of Desmopressin in Hyponatremia: Foe and Friend
Use of desmopressin (1-deamino-8-d-arginine vasopressin; DDAVP), a synthetic vasopressin receptor agonist, has expanded in recent years. Desmopressin leads to renal water retention, and iatrogenic hyponatremia may result if fluid intake is not appropriately restricted. It is common practice to stop...
Main Authors: | Steven G. Achinger, Juan Carlos Ayus |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-03-01
|
Series: | Kidney Medicine |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2590059519300238 |
Similar Items
-
Desmopressin and the risk of hyponatremia: A population-based cohort study.
by: Michael Fralick, et al.
Published: (2019-10-01) -
ZEB Proteins in Leukemia: Friends, Foes, or Friendly Foes?
by: Bieke Soen, et al.
Published: (2018-06-01) -
The Role of Desmopressin in the Management of Severe, Hypovolemic Hyponatremia: A Single-Center, Comparative Analysis
by: Frank L. Ward, et al.
Published: (2018-03-01) -
Chronicity of Uncorrected Hyponatremia and Clinical Outcomes in Older Patients Undergoing Hip Fracture Repair
by: Juan Carlos Ayus, et al.
Published: (2020-06-01) -
Hyponatremia in the Dialysis Population
by: Connie M. Rhee, et al.
Published: (2019-06-01)